CTOs on the Move

Impeva Labs

www.impeva.com

 
Impeva Labs is a Mountain View, CA-based company in the Software and Internet sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.impeva.com
  • 2570 W El Camino Real Ste 440
    Mountain View, CA USA 94040
  • Phone: 650.872.7099

Executives

Name Title Contact Details

Similar Companies

pihms

pihms is a Pittsburgh, PA-based company in the Software and Internet sector.

Drivosity

Drivosity, LLC provides technology solutions that empower businesses with GPS tracking and real-time data on their delivery force. We measure drivers` behaviors to support data-driven improvements that help businesses better manage risks, inspire safer driving and increase productivity. Through our GPS tracking technology, Drivosity gives visibility and insight to the individual driving habits of your delivery force. Founded in December of 2015, Drivosity has become the go-to GPS-Based fleet tracking system for the top players in the food delivery industry. Logging over a million deliveries since its launch, Drivosity`s products have been proven to increase employee productivity, driver efficiency, and overall road safety for all drivers.

Transcend Software Inc

Transcend Software Inc is a Davenport, IA-based company in the Software and Internet sector.

Secure Auth

Secure Auth is a Irvine, CA-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.